A large study with follow-up over 14 years offers a unique way of looking at the risk of cancer among HIV-positive individuals by accounting for the competing risk of death in the era of highly effective antiretroviral therapy (ART), as reported today in the Annals of Internal Medicine.
Read the original article on the Kaiser Permanente website.